ThermoGenesis Holdings

THMO52

Penny Stock

$0.170.00%$0.00

Penny Stock

THMO52

$0.17

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.20
Prev. Close	$0.17
EPS	-3.98
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.69M
PE Ratio	-

	LOW	HIGH
Day Range	0.14	0.20
52 Week Range	0.10	1.41

Ratios

Revenue	-





EPS	-3.98

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About ThermoGenesis Holdings (THMO)

ThermoGenesis Holdings Inc (THMO) is a biomedical technology company focused on developing and commercializing automated technologies for cell-based therapies. The company's flagship product is the AutoXpress® System, a fully automated, closed, and functionally closed system for processing and cryopreserving hematopoietic stem cell (HSC) products. This technology enables the rapid and reproducible production of therapeutic doses of stem cells, which can be used for the treatment of various diseases, including blood cancers and genetic disorders. ThermoGenesis is also developing next-generation technologies for the isolation and processing of immune cells for cell-based immunotherapies.

In terms of its stock price history, ThermoGenesis Holdings Inc (THMO) has experienced significant volatility over the past year. The stock reached a high of $12.50 per share in January 2021, but has since declined to its current trading price of around $4.50 per share. This decline is likely due to a combination of factors, including market conditions, investor sentiment, and company-specific news. Despite the recent decline, ThermoGenesis Holdings Inc remains a promising player in the cell therapy industry, which is expected to grow at a rapid pace in the coming years.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. Xiaochun Xu M.B.A., Ph.D.
Headquarters: Rancho Cordova
Employees: 40
Exchange: NASDAQ

Keep an eye on ThermoGenesis Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is ThermoGenesis Holdings 's (THMO) price per share?

The current price per share for ThermoGenesis Holdings (THMO) is $0.17. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for ThermoGenesis Holdings (THMO)?

For ThermoGenesis Holdings (THMO), the 52-week high is $1.41, which is 729.41% from the current price. The 52-week low is $0.1, the current price is 70% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is ThermoGenesis Holdings (THMO) a growth stock?

ThermoGenesis Holdings (THMO) has shown an average price growth of 0.41% over the past three years. It has received a score of -4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ThermoGenesis Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is ThermoGenesis Holdings (THMO) stock price performance year to date (YTD)?

As of the latest data, ThermoGenesis Holdings (THMO) has a year-to-date price change of -69.7%. Over the past month, the stock has experienced a price change of 20.74%. Over the last three months, the change has been -19.43%. Over the past six months, the figure is -77.33%.

help

Is ThermoGenesis Holdings (THMO) a profitable company?

ThermoGenesis Holdings (THMO) has a net income of -$18.92M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 20.44% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -20.35% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $1.93M. Operating income is noted at -$8.61M. Furthermore, the EBITDA is -$4.87M.

help

What is the market capitalization of ThermoGenesis Holdings (THMO)?

ThermoGenesis Holdings (THMO) has a market capitalization of $2.69M. The average daily trading volume is 25.64K, indicating the stock's liquidity and investor engagement.